Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

NeoStem receives second year of grant for very small embryonic-like stem cells

April 3, 2013

No Comments

New agents for substance abuse and dependence divulged by Gilead Sciences

March 27, 2013

No Comments

FDA committee recommends approval of Probuphine

March 22, 2013

No Comments

Omeros identifies mechanism of action of its PDE7 inhibitors in addiction

March 21, 2013

No Comments

Researchers develop novel animal models of pediatric OP-induced SE

March 21, 2013

No Comments

Lundbeck's Selincro approved in E.U. for alcohol dependence

March 1, 2013

No Comments

MediciNova's MN-166 gets fast track designation from FDA

Feb. 26, 2013

No Comments

The University of Bath designs agents for drug and alcohol abuse

Feb. 7, 2013

No Comments

Novel compounds described as potential therapies for nerve agent poisoning

Feb. 4, 2013

No Comments

OrbeShield granted fast track designation for gastrointestinal ARS

Jan. 30, 2013

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Substance use and poisoning
RSS

NeoStem receives second year of grant for very small embryonic-like stem cells

New agents for substance abuse and dependence divulged by Gilead Sciences

FDA committee recommends approval of Probuphine

Omeros identifies mechanism of action of its PDE7 inhibitors in addiction

Researchers develop novel animal models of pediatric OP-induced SE

Lundbeck's Selincro approved in E.U. for alcohol dependence

MediciNova's MN-166 gets fast track designation from FDA

The University of Bath designs agents for drug and alcohol abuse

Novel compounds described as potential therapies for nerve agent poisoning

OrbeShield granted fast track designation for gastrointestinal ARS

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

Apollo signs near-$1B deal for Sunshine’s FGF21/GLP-1 injection

Substance use and poisoning RSS

Substance use and poisoning
RSS